Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
Gastroenterology 156(2) (2018)
Thomas F. Baumert; Thomas Berg; Joseph K. Lim; David R. Nelson
Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting
Journal of Hepatology 71(6) (2019)
Radha Krishan Dhiman; Gagandeep Singh Grover; Madhumita Premkumar; Sunil Taneja; Ajay Kumar. Duseja; Sanjeev Arora; Sahaj Rathi; Sandeep Satsangi; Akash Roy
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
International Journal of Drug Policy 72 (2019)
Maryam Alavi; Hossein Poustchi; Shahin Merat; Soudeh Kaveh; Afarin Rahimi‐Movaghar; Behrang Shadloo; Behzad Hajarizadeh; Jason Grebely; Gregory J. Dore; Reza Malekzadeh
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
World Journal of Gastroenterology 27(29) (2021)
Brittany Burns Dennis; Leen Naji; Yasmin Jajarmi; Aijaz Ahmed; Donghee Kim
Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
Journal of Clinical and Experimental Hepatology 7(3) (2017)
Madhumita Premkumar; Gagandeep Singh Grover; Radha Krishan Dhiman
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Hepatitis Monthly 17(11) (2017)
Seyed Moayed Alavian; Heidar Sharafi
An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
International Journal of Drug Policy 102 (2022)
Ali Mirzazadeh; Samira Hosseini‐Hooshyar; Armita Shahesmaeili; Heidar Sharafi; Mohammad Shafiei; Jasem Zarei; Ghazal Mousavian; Fatemeh Tavakoli; Nima Ghalekhani; Mostafa Shokoohi; Mehrdad Khezri; Soheil Mehmandoost; Mohammad Reza Shojaei; Mohammad Karamouzian; Alya Briceño; Meghan D. Morris; Seyed Moayed Alavian; Ali Akbar Haghdoost; Hamid Pour Sharifi; Kimberly Page
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
BMJ Open 12(6) (2022)
Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena Hiemisch Lobo Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh
A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting
Harm Reduction Journal 17(1) (2020)
Sanam Hariri; Maryam Sharafkhah; Maryam Alavi; Gholamreza Roshandel; Abdolreza Fazel; Taghi Amiriani; Nazgol Motamed-Gorji; Abolfazl Bazazan; Shahin Merat; Hossein Poustchi; Reza Malekzadeh
Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan
Journal of Medical Virology 92(12) (2020)
Saima Mushtaq; Atika Mansoor; Muhammad Umar; Amjad Khan; Saima Siddiqi; Sobia Manzoor
Efficacy and safety of generic daclatasvir + sofosbuvir ± ribavirin in treatment of genotype 3 infected hepatitis C patients - a real life experience from Pakistan
Hepatoma Research 4(11) (2018)
Muhammad Umar; Tayyab Saeed Akhter; Junaid Sadiq; Samar Saleem; Shoaib Khokhar
Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia
Journal of Virus Eradication 5(2) (2019)
Masoud Behzadifar; Hasan Abolghasem Gorji; Aziz Rezapour; Nicola Luigi Bragazzi
Response of Daclatasvir and Sofosbuvir in Treatment-Naïve, HCV Genotype 3, Non-Cirrhotic Pakistani Population: 1 Year Follow-Up Experience
Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University 19(2) (2023)
Nadeem Islam; Shirin Aamir; Aleena Hussain Rana; Syed Mohsin Naveed; Mujeeb Ur Rehman
Methadone Maintenance Therapy (MMT) Clients Should Be More Noticed for Hepatitis C Elimination in Iran
Thrita 6(2) (2017)
Hamidreza Karimi‐Sari; Seyed Moayed Alavian